Furthermore, we show in a pharmacological approach that chronic fluoxetine attenuates depression-like behavior (24) and normalizes aspects of deranged circadian locomotor activity in parallel with the hippocampal clock gene cry2, suggesting an association between these molecular markers and the behavioral phenotype beyond genetic drift. Here, CRY2 is linked to depressive symptom measurement.